Effects of exercise during adjuvant chemotherapy on breast cancer outcomes

Medicine and Science in Sports and Exercise

Volumn 46, Issue 9, 2014, Pages 1744-1751

  Courneya, Kerry S ^a   Segal, Roanne J ^b   McKenzie, Donald C ^c   Dong, Huiru ^a   Gelmon, Karen ^c,d   Friedenreich, Christine M ^e   Yasui, Yutaka ^a   Reid, Robert D ^f   Crawford, Jennifer J ^a   MacKey, John R ^a,g  

^a UNIVERSITY OF ALBERTA   (Canada)

^b OTTAWA REGIONAL CANCER CENTRE   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

^e ALBERTA HEALTH SERVICES   (Canada)

^f UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^g CROSS CANCER INSTITUTE   (Canada)

Author keywords

Disease Free Survival; Physical Activity; Randomized Controlled Trial; Recurrence; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; BRIDGED COMPOUND; ESTROGEN RECEPTOR; TAXANE; TAXOID;

ADJUVANT CHEMOTHERAPY; BREAST NEOPLASMS; CANCER STAGING; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KINESIOTHERAPY; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; OBESITY; PATHOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SURVIVAL RATE; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; BRIDGED COMPOUNDS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OBESITY; RECEPTORS, ESTROGEN; RESISTANCE TRAINING; SURVIVAL RATE; TAXOIDS; TREATMENT OUTCOME;

EID: 84906944783     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0000000000000297     Document Type: Article

References (26)

1. Ballard-Barbash R, Friedenreich CM, Courneya KS, et al. Physical activity, biomarkers, and disease outcomes in cancer survivors: A systematic review. J Natl Cancer Inst. 2012;104(11):815-40.
2. Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: The results of 20 years of follow-up. N Engl J Med. 1995;332:901-906.
3. Budman DR, Berry DA, Cirrincione CT, et al. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. J Natl Cancer Inst. 1998;90(16):1205-11.
4. Cannistra SA. Phase II trials in journal of clinical oncology. J Clin Oncol. 2009;27(19):3073-6.
5. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;20(4):1128-43.
6. Chlebowski RT, Blackburn GL, Thomson CA, et al. Dietary fat reduction and breast cancer outcome: Interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst. 2006;98(24):1767-76.
7. Courneya KS, Booth C, Gill S, et al. The Colon Health and Life-Long Exercise Change trial: A randomized trial of the National Cancer Institute of Canada Clinical Trials Group. Curr Oncol. 2008;15(6):279-85.
8. Courneya KS, Segal RJ, Mackey JR, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: A multicenter randomized controlled trial. J Clin Oncol. 2007;25(28):4396-404.
9. Fairey AS, Courneya KS, Field CJ, et al. Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: A randomized controlled trial. Brain Behav Immun. 2005;19(5):381-8.
10. Fairey AS, Courneya KS, Field CJ, Jones LW, Mackey JR. Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J Appl Physiol (1985). 2005;98(4):1534-40.
11. Friedenreich CM, Gregory J, Kopciuk KA, Mackey JR, Courneya KS. Prospective cohort study of lifetime physical activity and breast cancer survival. Int J Cancer. 2009;12(8):1954-62.
12. Hambrecht R, Hilbrich L, Erbs S, et al. Correction of endothelial dysfunction in chronic heart failure: Additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol. 2000;35(3):706-13.
13. Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000;324(70):454-60.
14. Hudis CA, Barlow WE, Costantino JP, et al. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system. J Clin Oncol. 2007;25(15):2127-32.
15. Ibrahim EM, Al-Homaidh A. Physical activity and survival after breast cancer diagnosis: Meta-analysis of published studies. Med Oncol. 2011;28(3):753-65.
16. Irwin ML, McTiernan A, Baumgartner RN, et al. Changes in body fat and weight after a breast cancer diagnosis: Influence of demographic, prognostic, and lifestyle factors. J Clin Oncol. 2005; 23(4):774-82.
17. Ji LL. Exercise-induced modulation of antioxidant defense. Ann N Y Acad Sci. 2002;959:82-92.
18. Kraus RM, Stallings HW, Yeager RC, Gavin TP. Circulating plasma VEGF response to exercise in sedentary and endurancetrained men. J Appl Physiol (1985). 2004;96(4):1445-50.
19. McTiernan A, Tworoger SS, Rajan KB, et al. Effect of exercise on serum androgens in postmenopausal women: A 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2004; 13(7):1099-105.
20. Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci. 2002;57(10):B359-65.
21. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793-801.
22. Pierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: The Women's Healthy Eating and Living (WHEL) randomized trial. JAMA. 2007;298(3): 289-98.
23. Rock CL, Byers TE, Colditz GA, et al. Reducing breast cancer recurrence with weight loss, a vanguard trial: The Exercise and Nutrition to Enhance Recovery and Good Health For You (ENERGY) trial. Contemp Clin Trial. 2012;34(2):282-95.
24. van Baak M. Influence of exercise on the pharmacokinetics of drugs. Clin Pharmacokinet. 1990;19(1):32-43.
25. Villarini A, Pasanisi P, Traina A, et al. Lifestyle and breast cancer recurrences: The DIANA-5 trial. Tumori. 2012;98(1):1-18.
26. Wood WC, Budman DR, Korzun AH, et al. Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med. 1994;330(18):1253-9.